Brand Name : Natdac
Active Ingredient : Daclatasvir Dihydrochloride
Manufactured by : Natco Pharma Ltd.
Strength : 60 mg
Form : Tablets
Packing : Pack of 28 Tablets
For hepatitis C sufferers, Natdac could make the difference between life and death.
Hepatitis C results in more deaths worldwide than malaria, HIV or TB, but there’s good news about this blood-borne virus, which can lead to liver cancer or cirrhosis. Natdac Daclatasvir, a generation of direct-acting anti-viral drugs offer a high cure rate, with few side effects and shorter treatment times.
Natdac Daclatasvir is an Nonstructural protein 5A (NS5A) inhibitor that is used only in combination with another drug — Sofosbuvir a polymerase inhibitor — to treat chronic hepatitis C virus infections. Natdac generic medicine can be used to cure disease in several different genotypes, and has shown cure rates of 97% during clinical trials as same their brand name drug “DAKLINZA”. The cure rate depends on several factors including the strain of the virus and specific subgroups of patients (e.g. genotype related, cirrhosis related, age related, weight related).
“The advent of this powerful HCV medicine for the treatment of hepatitis C virus opened the door to unprecedented treatment response in a significantly shorter amount of time.“
Drugssquare is an authorized online pharmacy, formed in 2012. At the global level, we have made significant contribution in saving the lives of millions and in bringing down the prices of lifesaving drugs used to treat diseases such as HIV, HCV and cancer by as much as 90 per cent.